Our manufacturing sites are state-of-the-art, powered by big data and digital. It is by producing vaccines that our mission takes on its full meaning. It is the bridge between scientific advances and transformative medicine serving millions of people around the world.
We are adding two new Evolutive Vaccines Facilities to our global industrial footprint. These production units (EVF) represent the future of vaccine manufacturing. They allow us to increase our capacities while making production more flexible and respectful of the environment. We are currently in the construction phase of these two EVFs, one in France and the other in Singapore.
dedicated to quality
global producer of
Evolutive Vaccines Facilities
Pushing manufacturing to the next level
Fully digitalized, our Evolutive Vaccines Facilities (EVF) will enable more responsive and flexible manufacturing across multiple vaccine and biological platforms including mRNA, while minimizing our impact on the environment. Our EVFs will help improve people’s lives by giving them faster access to more vaccines and treatments.
The benefits of EVFs
- Up to 4 vaccines can be produced simultaneously on the same production site
- It will take about 12 days to go from producing one vaccine to another
- Nearly carbon-neutral using green electricity or power from the site’s own solar panels
What is an Evolutive Vaccine Facility
Taking vaccines from the lab to vial and beyond
Vaccine manufacturing is a complex process that shepherds sensitive biological material from the lab to the vial and beyond.
Our vaccines are held to the highest standard of safety. Prior to the approval by the health authorities, our vaccines are tested extensively to ensure they are effective and safe. Once in use, they are also continually monitored for safety through our pharmacovigilance system. Sanofi develops, manufactures and distributes vaccines that respect regulatory requirements and our company’s values.
We are committed to making the safest and most effective vaccines possible available everywhere in the world.
Find out how our vaccines are made
Voices from Industrial Affairs
Our teams are proud to contribute to a better world thanks to vaccines.
Episode 2: Kevin
The importance of being rigorous in vaccine quality testing: Kevin explains.
This page last update: 02-2022